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Abstract
Despite modern sequencing efforts, the difficulty in assembly of
highly repetitive sequences has prevented resolution of human
genome gaps, including some in the coding regions of genes with
important biological functions. One such gene,MUC5AC, encodes
a large, secretedmucin,which is oneof the twomajor secretedmucins
in human airways. TheMUC5AC region contains a gap in the human
genome reference (hg19) across the large, highly repetitive, and
complex central exon. This exon is predicted to contain imperfect
tandem repeat sequences and multiple conserved cysteine-rich
(CysD) domains. To resolve theMUC5AC genomic gap, we used
high-fidelity long PCR followed by singlemolecule real-time (SMRT)
sequencing. This technology yielded long sequence reads and robust
coverage that allowed for de novo sequence assembly spanning the
entire repetitive region. Furthermore, we used SMRT sequencing of
PCRamplicons covering the central exon to identify genetic variation
in four individuals. The results demonstrated the presence of
segmental duplications of CysD domains, insertions/deletions
(indels) of tandem repeats, and single nucleotide variants. Additional
studies demonstrated that one of the identified tandem repeat
insertions is tagged by nonexonic single nucleotide polymorphisms.
Taken together, these data illustrate the successful utility of SMRT
sequencing long reads for de novo assembly of large repetitive
sequences to fill the gaps in the human genome. Characterization of
theMUC5AC gene and the sequence variation in the central exonwill
facilitate genetic and functional studies for this critical airwaymucin.
Keywords: MUC5AC; single molecule real time sequencing;
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Mucins (MUC1–MUC22) are highly
glycosylated proteins with important
host-defense functions in lung and other
organs. Secreted gel-forming mucins on
epithelial surfaces contribute to the highly
specialized biochemical matrices critical for
epithelial protection and defense. In the
airway, MUC5AC and MUC5B are major
constituents of mucus, which is critical for
mucociliary clearance, a key innate defense
against respiratory insults (1). In the gut,
MUC2, MUC5AC, and other mucins
contribute to the barrier that maintains
gastrointestinal homeostasis in the presence
of the very acidic environment of the
stomach and the huge bacterial burdens in
the intestine (2–4). Like secreted (or gel-
forming) mucins, transmembrane-
anchored mucins contribute to airway host
defense via the epithelial glycocalyx, where
they can limit pathogen and particle access
(5, 6).
The role of mucins in maintaining
organismal homeostasis is highlighted by
the diseases developing under conditions of
defective mucin function. Loss of airway
mucociliary clearance, which is dependent
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on secreted mucins, leads to severe
respiratory diseases, such as chronic
obstructive pulmonary disease and cystic
fibrosis (CF). In mice, loss of Muc5AC
increases susceptibility to intestinal
nematodes and alters responses to
ventilator-induced lung injury (7, 8). In
the gut, expression, secretion, and
glycosylation of MUC2/Muc2 contribute to
inflammatory bowel diseases (9–12). New
data point to the importance of mucin/
pathogen interactions for gastric ulcers
associated with Helicobacter pylori infection
(13–15). Recently, mutations in MUC1
were shown to cause medullary cystic
kidney disease type 1 (16).
Recent genetic studies further implicate
mucin gene function in human disease. For
example, a common polymorphism in the
promoter of MUC5B is associated with
idiopathic pulmonary fibrosis (17–19). In
our own recent work, a specific 6.4-kb HinfI
allele–length polymorphism was shown to
associate with more severe lung disease in
CF (20). MUC5AC and MUC5B are located
in the subtelomeric, recombination-rich
region on chromosome 11p15.5, which
contains several mucin genes, from telomere
to centromere, MUC6-MUC2-MUC5AC-
MUC5B (21). The Genome Reference
Consortium (GRCh37) and human genome
reference (hg19) sequences have a gap
between the 59 and 39 exons of MUC5AC
(see Figure 1A for overview) that is at least
partially comprised of an unusually large
central exon encoding the tandem repeats
(TR) (previously described in the literature
as “variable number of tandem repeats”) and
several highly similar cysteine-rich (CysD)
regions (22, 23). The MUC5AC TR
translates into an eight-amino-acid repeat
rich in proline, threonine, and serine (PTS-
TR). PTS-TR domains are characteristic of
most mucin proteins and are often encoded
by single exons representing the heavily
O-glycosylated protein domains critical for
mucin function (24). Southern blots have
been used to describe the general nature of
the genetic length variation in PTS-TR
regions (25, 26), but specific sequence
details of the polymorphic alleles are not
available. Because of their highly repetitive
and complex nature, these regions for
many mucin genes are inadequately or
inaccurately defined (27) and, in the case of
MUC5AC, contribute to a sequence gap in
GRCh37/hg19.
The deficiency in genomic references
and poor annotation has led to a failure to
fully represent mucins, such as MUC5AC,
on exome chips, gene expression
microarrays, and high-density single
nucleotide polymorphism (SNP) panels.
Thus, there is poor representation in
genome-wide studies, and results from
global expression studies are often
inaccurate. In addition, large-scale genomic
efforts (e.g., the Encyclopedia of DNA
Elements [ENCODE; http://encodeproject.org],
which seeks to understand global gene
expression regulatory elements), fail to
adequately query regions that lack high-
quality reference sequences.
Third-generation, single-molecule
sequencing technology, such as single
molecule real-time (SMRT) sequencing by
Pacific Biosciences (PacBio), provides
relatively long sequence reads and offers an
opportunity to overcome some of the
difficulties (28, 29) that have prevented the
availability of a reliable MUC5AC gene
reference. We have successfully used this
technology to (1) confirm the 59 and 39
structure of MUC5AC; (2) determine the
missing sequence across the public
GRCh37/hg19 gap in MUC5AC and
demonstrate that it contains a single, large,
complex central exon; and (3) characterize
the structural variants, insertion/deletion
(indel) variants, and SNPs among four
subjects in this highly polymorphic exon.
The results provide a solid basis for future
efforts to define MUC5AC functional
genetic variants for biological, mechanistic,
and genetic association studies.
Materials and Methods
Selection of Subjects
Four subjects were analyzed, one nonCF
African American (AfrAm) subject available
through Duke University’s airway cell
repository (30) and three white F508del
homozygote CF subjects (labeled CauCF1,
CauCF2, and CauCF3) from the University
of North Carolina/Case Western Reserve
University Genetic Modifier Study
population (31). Relevant features of the
subjects together with the DNA source and
isolation strategy are listed in Table E1 in
the online supplement. The three white
subjects with CF were selected to represent
common haplotypes on the basis of the
MUC5AC HinfI fragment length and SNP
genotypes previously reported (20). This
study was conducted in accordance with
institutional review board approvals.
Gene Model and Confirmation in the
AfrAm Subject
DNA from the AfrAm subject was used to
confirm a gene model built from existing
genomic scaffold sequences (17, 22)
(Figure 1). On the basis of this model, 11
pairs of primers were designed to produce
seven overlapping products (Phase 1). In
Phase 2, eight pairs of PCR primers
targeting two regions not well covered in
Phase 1 were used (Figure 1C; Table E2).
The PCR primer pairs were designed using
Primer-Blast from the National Center for
Biotechnology Information (NCBI) (32)
(Table E2). Additional details are provided
in the online supplement.
Amplifying the Central Repetitive
Region of MUC5AC in Subjects
CauCF1, -2, and -3
There are two reasons for the focus on
subjects CauCF1, -2, and -3: 1) to determine
the sequence across the predicted central
exon and 2) to define the polymorphic
nature of allele sizes demonstrated for these
three subjects on Southern blots for this
region. A pair of unique primers was
designed to amplify the central repetitive
region in MUC5AC (Figure 1C). Additional
details can be found in the online
supplement.
Sequence Assembly
Details of the methods applied for
sequencing runs, sequence assembly, and
sequence processing are provided in the
online supplement. Sequencing reads
greater than 3 kb from the AfrAm individual
were analyzed using the assembly tools in
SMRT Portal (ALLORA; V1 Pacific
Biosciences, Menlo Park, CA). Alignment of
multiple contigs and merging of two contigs
were accomplished by using Vector NTI
(Life Technologies, Grand Island, NY).
Alignment of genomic DNA and mRNAs
was performed using Spidey from NCBI
(http://www.ncbi.nlm.nih.gov/spidey/),
and translation of DNA to protein was
performed using a web-based translation
tool (http://insilico.ehu.es/translate/)
(33). Alternatively, for the CauCF subjects,
SMRT sequencing reads were filtered by
size, and de novo assembly was conducted
using the current production release of
MIRA v3.4 (http://www.chevreux.org/
projects_mira.html) (34) with custom
tuned parameters and minimum read
length of 1 kb.
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Confirmation of Duplication of 59
Region Conserved Duplicon
in CauCF3
A PCR method described in the online
supplement was developed to confirm the
duplication containing two extra internal
CysD domains at the 59 portion of the
central repetitive region in CauCF3. In
addition, direct genomic DNA sequencing
from CauCF3 was conducted. Details of the
sequencing and the subsequent analyses of
this enriched DNA are given in the online
supplement. Briefly, BsbI-digested genomic
fragments from CauCF3 were size selected
(z 9–15 kb) on agarose gels and purified
via electroelution. Because BsbI is predicted
to cut outside the central repetitive region,
the size selection would leave the region
intact while enriching the sample for the
DNA of interest.
Results
Defining the MUC5AC Sequence and
Genomic Gap in an African-
American Subject
Recent builds of the human genome
reference (GRCh37/hg19) have a gap where
MUC5AC resides (Figure 1). On the basis of
the data presented here, an accurate picture
of this genomic region has been obtained,
including all intron/exon sequences
(Figures 2 and E1). Specifically, de novo
assembly of the AfrAm subject sequence
(Figure E1), consisting of two large contigs
(contigs 1 and 2) (Figure 2A and Table E3),
confirms the general structure of the gene
model, which used various pieces of
available sequence (Figure 1B). Sequencing
of the AfrAm subject (Figure E1) confirmed
the integrity of the High Throughput
Genomics Center (http://www.ncbi.nlm.nih.
gov/genbank/htgs) working draft FP326773
(Figure 1B).
Figure 1. MUC5AC genomic region. Current status and research design to cover theMUC5AC genomic gap. (A) Annotation tracks for theMUC5AC region
excerpted from the University of California Santa Cruz genome browser (http://genome.ucsc.edu) (GRCh37/hg19) with notes added to emphasize the gap.
The current gap in the MUC5AC gene is situated between a set of exons (blue vertical bars along arrowed line) that are 59 (the 59 exons are incorrectly
annotated toMUC5B) and a set of 39 exons (that are correctly annotated toMUC5AC). The entire region is in general disarray. (B) Available sequences used
to inform the selection of PCR primers to characterize the gene, with a focus on filling the gap. The PCR primer selection was based on the use of the human
reference alternative assembly genomic scaffold sequence NW_001838016 and other existing cDNA and genomic sequences. The High Throughput
Genomics (http://www.ncbi.nlm.nih.gov/genbank/htgs) working draft sequence FP326773 became available during the course of this work, and it differs
from NW_001838016 in length in the regions indicated. Together, these two sequences provide information for the 59 end of the gap and contribute to the
gene model. From previous efforts, there is strong evidence that the 39 end portion of the gap consists of the MUC5AC large central exon. The available
sequences in the large central exon region that were used to inform the PCR strategy consisted of one partial mRNA (AJ298317) and two partial genomic
PCR sequences (AJ298318 and AJ298319) (22). These sequences were used in conjunction with NW_001838016 and FP326773 to generate a gene
model, which was consistent with previous efforts (17). (C) Schematic representation of the overlapping PCR products used in contig development for de
novo assembly of the MUC5AC gene from the African American (AfrAm) subject and the region of focus for white subjects with cystic fibrosis (CauCF1–3).
The AfrAm individual was sequenced in two phases (Phase 1 and 2) as described in MATERIALS AND METHODS (further details are provided in Table E2).
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The MUC5AC gene contains 49 exons
in the AfrAm individual (Figures 2B
and E1). Location and sequences of the
intron–exon boundaries, intron and exon
sizes, and splice junction sequence are
provided in Figure E1 and Table E4.
After additional processing of the sequence
(details are provided in the online
supplement), the full-length predicted
mRNA sequence was translated into
5,654 amino acids and had the structural
organization/features as presented in
Figure 2C. Most of the translation aligned
well to p98088, the Uniprot MUC5AC
reference protein sequence primarily
translated from mRNA sequences (http://
www.uniprot.org/uniprot/P98088);
however, differences between the two
sequences are noted in Figure 3 (blue and
green horizontal bars). The sequences
encoding these amino acids represented the
sequences linking the previously available
sequences (22, 35), essentially filling the
gaps between AJ298317 and AJ298319
(Figures 1B and 1C, dashed horizontal
lines). We confirmed the original
hypothesis that the 39 region of the
genomic gap in GRCh37/hg19 consisted of
one large central repetitive exon (exon 31)
encompassing the TR (PTS-TR) and nine
CysD domains. The CysD domains are
characterized in this study into three classes
on the basis of sequence alignment
(Figure E2), a concept that has previously
been proposed (22) but was expanded on
for discussion purposes in this manuscript.
The 59 CysD domains combined with
adjacent flanking sequences are referred to
as “59 region conserved duplicon” and
the 39 CysD domain of the central exon,
combined with adjacent flanking sequences,
is referred to as a “39 region conserved
CysD segment” throughout this paper
(Figure 3).
De Novo Sequence Assembly from
Three White Subjects with CF
Produced Consensus Contigs
Representing Two Alleles for the
Large Central Exon from
Each Subject
Alignment of the sequences obtained from
the PCR amplicons in the central exon (exon
31) region of three white subjects (CauCF1,
CauCF2, and CauCF3) confirmed their
identity as MUC5AC sequences (data not
shown). MIRAv3.4 assembler software
Figure 2. MUC5AC gene defined in an AfrAm subject. (A) Schematic representation of de novo assembled sequence contigs produced from Pacific
Biosciences sequencing of pooled PCR product sequences from the AfrAm subject. The relative sizes of the contigs are shown roughly to proportion,
and the predicted gap size for the reference genome is 22.1 kb based on the location of flanking GRCh37/hg19 sequences. (B) Schematic representation
of MUC5AC gene showing exon locations. The large central exon is predicted to be exon 31, containing nine CysD domains and the tandem repeat
(PTS-TR) sequences. (C) Schematic MUC5AC mRNA protein translation showing the major protein domains and their relationship to the entire gene and
the central exon. The central exon consists of a 59 region characterized by one Class I CysD domain, duplicated pairs of Class II and Class III CysD
domains, and adjacent homologous sequence, which is rich in prolines, threonines, and serines (PTS region). The 39 half of the central exon has a different
structure, which is characterized by Class III CysD domains and adjacent unique sequences separated by PTS-TR units (TR1–4) of 24-bp imperfect
repeats. Other protein features shown were previously defined (22). C domain = von Willebrand factor type C domain; CK domain = C-terminal cysteine
knot domain; D domain = von Willebrand factor type D domain. The definition of the CysD domain classes is provided in the text.
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successfully produced two consensus alleles
for each CauCF individual when the
filtering and processing criteria described in
the methods were applied (Figures E3 and
E4; Table E3). These consensus contigs
were obtained even under circumstances
when the dominant PCR product, before
library preparation, was not full length
(Figure E3A). Despite its highly repetitive
nature, the central exon sequences obtained
from de novo assembly from all three
CauCF individuals were considered to be
highly reliable for the following reasons:
(1) the sequences were verified to contain
a long open reading frame (ORF) encoding
the PTS-TRs and CysD domains,
consistent with previously published results
and available protein sequences (22)
(Figures 3 and E5); (2) the predicted HinfI
fragments sizes produced from the de novo
assembly closely matched previously
obtained Southern blot data (Table E1),
with slight differences likely reflecting the
inability to precisely determine the size of
fragments on Southern blots, especially in
this large size range (20); and (3) the
presence of canonical exon 39-splice
junction with GT donor sequence for the
large central exon as predicted if the ORF
would be continued via splicing to exon 32
(data not shown).
The DNA and protein sequence
accession identification numbers, deposited
into NCBI, are listed in Table 1. The lengths
of the central exon in the four subjects were
10.25, 10.25, 10.5, and 12.25 kb for the
AfrAm, CauCF1, CauCF2, and CauCF3
subjects, respectively. Thus, the extremely
large central exon of MUC5AC joins the
ranks of other mucins (i.e., MUC16 . 21;
MUC4 12.7;MUC12 14.9;MUC17 12.2; and
MUC5B 10.9 kb) and large proteins, such as
titin (TTN . 17 kb), as one of the longest
exons in the human genome (36). For
illustrative purposes, we have defined at
least 26 domains or subdomains (including
unique sequences) for the AfrAm, CauCF1,
and CauCF2 subjects and 34 for CauCF3
(Table E5), all of which likely contribute to
genetic diversity, evolutionary history, and/
or protein function. Although the PTS-TR
region clearly consists of repeated units of
24 nucleotides (eight amino acids), the
majority of PTS-TRs are not identical, with
Figure 3. Genetic variants and organization of the MUC5AC central exon. Sequence schematics representing the MUC5AC central exon from the
AfrAm subject and three white subjects with cystic fibrosis produced by de novo assembly were compared, as a group and individually, with the central
exon model (22), and the results are shown. All four subjects in this study have larger PTS-TR1 (extra 1.9 kb, blue bar) and PTS-TR4 (extra 216 bp, green
bar) regions than the draft genome model sequence (Figure 1B). The increase in the PTS-TR lengths, when compared with the previously known
model, more specifically shown in the central exon model of this figure, effectively link the previously available genomic fragments (Figure 1) into one unit
and complete the central exon sequence. Indels are shown as purple bars, pink bars, or black stars. The three classes of CysD domains are shown
(colored ovals). The duplication of the CysD domains in CauCF3, as compared with other subjects, is indicated by CysD4a, CysD5a, and CysD6a. HinfI
sites are shown by red arrows, and the small and large HinfI fragment lengths identified by Southern blots are shown in red text, which are very similar
to the in silico sizes (blue text).
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considerable sequence diversity. However,
there are commonly seen identical repeat
units among the different PTS-TR regions
(TR1–TR4) (Tables E5 and E6).
Genetic Variants in the Large
Central Exon
Successful generation of de novo contigs,
coupled with alignments, allowed for the
identification of the genetic variants in the
central exon across the four individuals
(Figure 3; details provided in Figure E5).
Several types of genetic variants were
identified, including SNPs, PTS-TR
insertions/deletions (indels), and segmental
duplications. The sequence structure of the
AfrAm subject was highly similar to
CauCF1. The AfrAm and CauCF1 subjects
differed from the CauCF2 subject by the
insertion of eight and three 24-bp repeat
units in PTS-TR1 and PTS-TR4,
respectively. Although the AfrAm and
CauCF1 and -2 subjects contained nine
CysD domains, similar to the central exon
model, the CauCF3 subject contained two
segmental duplications that introduced
three additional CysD domains: an
additional Class II domain (labeled CysD4a)
and two additional Class III domains
(labeled CysD5a and CysD6a) (Figures 3
and E6). The first segmental duplication
giving rise to CysD4a and CysD5a likely
arose from an extra duplication of one 59
region–conserved duplicon containing one
Class II and one Class III domain
accompanied by flanking interspersed
sequences. The second segmental
duplication likely arose from a duplication
occurring after PTS-TR2 that included
CysD6a and the PTS-TRdup (Figure 3).
Confirmation of an Extra 59
Region–Conserved Duplicon
in CauCF3
Because the MUC5AC structural variations
presented in CauCF3 (Figure 3) have not
been reported previously, we sought to
confirm their presence through additional
testing (Figure 4). First, we were able to
obtain PCR fragments of the expected size
consistent with the duplication of the 59
region–conserved duplicon of CauCF3
(Figure 4A). End sequencing of the PCR
product isolated from the gel confirmed the
fragment’s identity at the correct position
in MUC5AC (data not shown). Direct
SMRT sequencing of unamplified, enriched,
BbsI-digested genomic DNA fragments
from CauCF3 (see MATERIALS AND METHODS
and the online supplement) produced
sequence reads spanning the central exon.
Over a dozen individual sequences spanned
the entire 59 region of the central exon, and
although each contained the expected
sequencing errors from the PacBio
platform, they all were shown to contain
seven CysD domains as predicted from the
de novo assembly of the SMRT Sequencing
reads previously produced from the PCR
amplicons (Figure 4B). Several other
sequences aligned across the region
containing CysD6a, confirming the
presence of an additional duplication in
that region. Moreover, when genomic
sequence reads mapping to the entire
MUC5AC gene model were used for de
novo assembly, they produced a contig that
reflected the structure of the 59 region of
the central exon that was determined from
sequencing of the PCR amplicon (three
Class II and three Class III CysD domains)
(Figure 4C). Sequencing of genomic DNA,
which was not subjected to amplification
and therefore was not biased by potential
PCR amplification related artifacts,
conclusively demonstrates the existence of
these duplication events in the individual
being studied. The data presented in
Figure 4 provide the necessary validation of
the integrity of the de novo assembled
contigs for CauCF3 and, importantly, they
confirm the reliability of the overall
strategy.
Strong Linkage Disequilibrium
between PTS-TR1 Genetic Variation
and SNP rs28514396
Previous evaluation of the linkage
disequilibrium (LD) structure of SNPs
across theMUC5AC gene has demonstrated
the existence of a few defined SNP “bins,”
where bins are defined as SNPs that
are in LD with each other (17). SNPs
representative of these bins were previously
shown to be in strong LD with PTS-TR
allele–size modes (20). The insertion
observed in PTS-TR1 of CauCF2 increases
the size of a HinfI fragment from 0.97 to
1.16 kb (Figure 3, in silico blue values).
Southern blots on a selected set of 276 white
subjects with CF were conducted (data not
shown) to test whether or not this PTS-TR1
HinfI-length polymorphism was in LD with
nearby SNPs. The Southern blots showed
the expected bimodal distribution of 0.95 or
1.15 kb (Southern blot red values are similar
to the in silico predicted blue values in
Figure 3) in the population. The analysis
found that the 1.15-kb HinfI fragment
including the insertion was in very strong
LD with the minor allele of SNP
rs28514396, which is approximately 7 kb
downstream from the 39 end of the central
exon (Fisher’s test P value , 2.2 3 10216)
(Table 2). Thus, rs28514396 can be used to
tag this PTS-TR1 genetic variant.
Discussion
De Novo Assembly Provides
a Reference Genome for Human
MUC5AC and Identifies Genetic
Variation in the Large, Repetitive
Central Exon
Using high-fidelity, long PCR coupled with
SMRT sequencing and state-of-the-art
assembly algorithms, this work reports the
complete sequence of the human MUC5AC
genomic region from an AfrAm individual
and the sequences of the large central
repetitive region from three white subjects
with CF. These sequences relied entirely on
de novo assembly of high-coverage long
sequence reads. De novo assembly had
previously been impossible using sequences
of shorter read lengths from Sanger and
second-generation sequence technologies in
this type of genomic gap. Significantly, the
sequence (1) spanned the current gap in the
GRCh37/hg19 genome reference (Figures 1
and 2), (2) solidified the intron–exon
structure (Figure 2), (3) identified genetic
variations associated with HinfI PTS-TR
fragment length polymorphisms assessed
by Southern blots (20) (Figure 3, data not
shown for AfrAm subject), (4) identified
additional significant structural variation
Table 1: DNA and Protein Accession
Identification Numbers in the National
Center for Biotechnology Information
Contig Name DNA ID Protein ID
AfrAm KC800812 AGR44427
CauCF1 c1* KC821598 AGI42861
CauCF1 c2* KC821599 AGI42862
CauCF2 c1* KC821600 AGI42863
CauCF2 c2* KC821601 AGI42864
CauCF3 c1* KC821602 AGI42865
CauCF3 c2* KC821603 AGI42866
Definition of abbreviations: AfrAm, African
American; CauCF, white subject with cystic
fibrosis.
*Alleles produced and sequenced for each
CauCF subject are shown (c1 and c2).
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generated by segmental duplications of
CysD domains (Figure 3), (5) characterized
the major functional domains coupled to
genetic variation and genome stability
(Figure E5; Table E5), (6) confirmed the
integrity of the SMRT sequencing strategy
by identification of segmental duplications
with direct sequencing of genomic DNA
(Figure 4), and (7) identified strong LD of
a specific indel in the PTS-TR1 with an
intronic SNP (Table 2).
Successful De Novo Assembly Using
Long SMRT Sequencing Reads
through the Highly Repetitive
Central Exon
The SMRT technology provides long
sequence reads from single DNA templates
(37). The C2 polymerase and C2
sequencing chemistry used for this work
generated average read lengths of 2.5 kb
and approximately 5% of reads approach
15 kb. These features were likely critical for
the success of the de novo assembly of
the MUC5AC central exon in this report.
On the other hand, the SMRT technology
is reported to produce sequences with
an error rate ranging from 10 to 15%
(38), which is higher than error rates
observed in second-generation sequencing
approaches. Mean error rates in the data
reported here were found to be around 10%
(Figure E7). Because the errors are
randomly distributed, they could be
Figure 4. Confirmation of structural variation in subject CauCF3 predicted from de novo assembly. (A) PCR primers located in CysD1 and PTS-TR1
were used to amplify genomic DNA. The expected increase in size (from 2.3 to 3.4 kb), consistent with the addition of a 59 region conserved duplicon,
was observed in CauCF3. (B) Long sequence reads from BbsI-enriched genomic DNA (see MATERIALS AND METHODS) from CauCF3 were mapped to the
de novo consensus contig 1 from CauCF3 using Burrows-Wheeler Aligner with custom parameters (49) and were visualized in the Integrated Genomics
Viewer software (50, 51). The black, purple, and red bars (Class I, Class II, and Class III, respectively) indicate location of the 12 CysD domains on
the de novo contig produced from the PCR amplification of the region from CauCF3. The gray horizontal bars show the individual BbsI-enriched genomic
DNA sequence reads mapped to the contig. The black bars, within the gray sequence reads, indicate regions within the individual sequences that have
a high indel content (consequence of SMRT Sequencing errors). Several individual sequence reads show the seven (CysD1–CysD5a) predicted CysD
domains at the 59 region. Several other individual sequence reads demonstrate the duplication of CysD6a in the 39 region. (C) Although the coverage was
not sufficient to produce a de novo assembly free of sequence errors across the entire region, six de novo assembled contigs were generated from the
low-coverage genomic DNA reads that mapped to the previously determined MUC5AC gene model (not shown). BLAST of CysD domain sequences
to one of these contigs demonstrates the arrangement of CysD domains expected from CysD4a-CysD5a duplication in CauCF3 contigs (purple: CysD2
aligning to Class II; red: CysD3 aligning to Class III). The dotted vertical lines mark the region in (B) and (C) for illustrative purposes.
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effectively dealt with bioinformatically by
obtaining high coverage coupled with
consensus error correction, ultimately
leading to an estimated final error rate of
less than 1/10,000 for the sequences reported
here. We estimate that greater than 303
coverage for each base is desired when using
SMRT sequencing for similar projects.
The methods used could achieve base
level resolution in identifying SNPs between
diploid alleles from each subject by nearly
50% representation of each allele among the
contigs. In addition, independent sequencing
of unamplified genomic DNA fragments
supported the results obtained when PCR
amplicons were sequenced. In conclusion,
our results demonstrated successful
application of the technology to produce de
novo assembled contigs in difficult regions
as long as sufficient long-read coverage is
obtained to allow consensus correction.
Optimizing the efficiency of amplification in
the PCR, with special attention paid to DNA
quality and environment, including gel
purification of expected amplicons, should
be considered in future studies.
Characteristics of the MUC5AC Gene
and Central Exon Genetic Variants
The MUC5AC sequences produced in this
report confirmed the original hypothesis
that the MUC5AC gap contained a single,
unusually large, exon encoding the previously
described PTS-TR sequences and CysD
domains (22, 23). The final consensus contigs
for the central repetitive region translated
into the predicted long ORFs in CauCF1, -2,
and -3 (Figure E5) and in the AfrAm subject
after additional sequence processing (details
are provided in the online supplement). In
addition, the assemblies produced identified
diploid features of the alleles of CauCF1, -2,
and -3 (Figure E4).
Although indels and SNPs in the
central exon among the four individuals
were identified, the most notable genetic
variants detected were two separate
segmental duplications (39) in CauCF3, the
subject that carries the longest HinfI
fragment (7.0 kb) (Figure 3, red arrows). A
duplication across two CysD domains from
Class II and Class III (including the
flanking PTS-rich regions) occurred in the
59 non–PTS-TR region of the exon in
CauCF3 (Figure 3). This structural variant
was confirmed by the expected increase in
PCR-fragment size in the region and by
SMRT sequencing of moderately enriched
genomic DNA (Figure 4). Another
duplication in the 39 region, consisting of
CysD6a and PTS-TRdup (Figure 3), was
found in CauCF3, which primarily explains
the increase in HinfI fragment size observed
on Southern blots.
The occurrence of MUC5AC genetic
variation in the central exon is likely driven
by genome instability (40) due to high
similarity in the PTS-TR sequences and
among the CysD domains. MUC5AC
resides in the subtelomeric region adjacent
to the end of the short arm of chromosome
11 (41) and specifically is found in the
middle of an approximately 300 kb
recombination-rich region among other
secreted mucins (from telomere to
centromere, MUC6-MUC2-MUC5AC-
MUC5B). Genes in subtelomeric regions are
often more genetically dynamic compared
with genes in other regions and are thought
to be under strong evolutionary pressure
influenced by host–environmental
interactions (42). Although the data are
limited to four individuals, the Class I, II,
and III CysD domains seem to have
different evolutionary outcomes. For
example, Class III CysD domains and
flanking unique sequences have expanded
within the PTS-TR region, likely through
PTS-TR–mediated duplications, and the 59
region conserved duplicon (composed of
Class II and Class III domains and the
flanking regions coding for PTS-rich
domains) has been replicated two (AfrAm,
CauCF1, and CauCF2) or three (CauCF3)
times. However, no similar duplication for
the Class I domain was observed (Figure 3).
Furthermore, the sequences immediately
flanking the 59 end of PTS-TR1 through the
39 end of PTS-TR4 (CysD5a and CysD9 in
CauCF3; CysD5 and CysD9 in all other
subjects) are different from the sequences
immediately flanking the CysD6 through
CysD8 domains (as shown in the
comparison for CauCF3 in Figure E6C; data
not shown for other subjects), a feature that
likely helps to prevent deletion of the entire
PTS-TR region during structural change.
There are other interesting features in
the MUC5AC PTS-TR1 through PTS-TR4
regions. First, all of the polymorphic
features (segmental duplications, SNPs, and
PTS-TR indels) in this region occur in the
context of one large exon where the
integrity of the ORF must be maintained.
Second, the only exception to the 24-bp
nucleotide repeat unit is the 14th repeat of
PTS-TR3, which is only 21 bp (Table E5,
red asterisk). Although these data clearly
support the concept of the eight-amino-acid
“repeat unit” in MUC5AC, these individual
PTS-TRs are quite variable, with no one
sequence accounting for more than 21% of
the total within the PTS-TR regions (Table
E6 and data not shown). Despite this
variation, the proline-threonine-serine rich
nature of the PTS-TRs is maintained
(sustaining the potential for O-linked
glycosylation), and negative selection
against glycosylation-disruptive mutations
most likely contributes to this phenomenon.
Intronic SNPs Can Tag PTS-TR
Length Variation in the MUC5AC
Central Exon
Subjects CauCF1, -2, and -3 were selected to
represent common haplotypes in the white
CF population, and further details of genetic
variation among the subjects in the central
repetitive region can now be provided.
CauCF1 contains the most common PTS-
TR allele (the 6.3-kb allele as defined in
Reference 20), and it is found on
chromosomes that contain primarily major
alleles of available SNPs across the entire
gene region. This supports the use of the
structure outlined for CauCF1, which is the
same as the AfrAm subject, as
a reasonable “working reference sequence”
to which other identified alleles can be
compared. Previous work on the LD
structure across the MUC5AC gene has
demonstrated that the minor alleles of
SNPs in the MUC5AC region can be
divided into “bins” based on their LD (17).
The insertion of eight repeat units in PTS-
TR1 of CauCF2 and CauCF3 generates an
increase in the HinfI fragment size, and we
speculated that this specific insertion may
Table 2: Association of Single Nucleotide
Polymorphism rs28514396 Genotype






0.95/0.95 kb 93 (98)† 2 (2) 0 (0)
0.95/1.15 kb 2 (2) 126 (98) 0 (0)
1.15/1.15 kb 0 (0) 3 (6) 50 (94)
*Detected by Southern blot in subjects with
cystic fibrosis from the University of North
Carolina/Case Western Reserve University
Genetic Modifiers Study (N = 276).
†Values are n (%). Fisher’s test P value ,
2.2 3 10216.
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be tagged with SNPs included on our
previous GWAS panels (43). This
speculation was supported by Southern blot
data conducted on 276 subjects that
specifically analyzed the smaller HinfI
fragment size. The HinfI fragment size
polymorphism was found to be in strong
LD with nearby SNPs; specifically it was
tagged by rs28514396 (Table 2). In previous
work, SNPs rs35705491, rs3087562, and
rs13380 were shown to be in strong LD
with the HinfI PTS-TR allele size mode
carried on CauCF3 (20), which we now
know differs from smaller alleles in part by
the duplication in the 39 region between
PTS-TR2 and CysD7 followed by the
deletion of the first six PTS-TR units
(Figure 3, black star in PTS-TRdup).
Moreover, we noticed two deletions of one
and four PTS-TR units in the PTS-TR4
region of this subject (Figure 3, black stars in
PTS-TR4). These genetic variants, and other
similar types of variations, likely account for
the larger mode of the bimodal distribution
in MUC5AC PTS-TR allele sizes previously
demonstrated (20, 25). We do not have
enough data to place the extra 59 region
conserved duplicon and the PTS-TR variants
on specific haplotypes, but further efforts
with additional subjects should provide this
information. More diversity and informative
features will surely be discovered as more
individuals are sequenced and analyzed.
Functional Consequences of CysD
Domain Copy Number Variation in the
Central Exon
The CysD domains, which were shown by
this work to vary in number between
individuals, are highly conserved across
many levels of eukaryotic taxonomies (42,
44). Although the 10 cysteines within these
domains are thought to be involved in
intramolecular disulfide bonds (45), the
specific function of these domains has not
been established. CysD domains are
common to secreted mucins, including all
secreted mucin genes found on human
chromosome 11 (MUC2, MUC5AC, and
MUC5B) (23, 42). Although they vary in
number among these mucins, they are
consistently found lying adjacent to or
scattered within the PTS-TR regions, where
they are reported to be less glycosylated
compared with their highly glycosylated
PTS-TR neighbors (46). Most of the
available literature on the function of the
CysD domains comes from work on the
CysD domain of MUC2, where it has been
shown that recombinant domains form
noncovalent dimers, probably via
hydrophobic interactions, suggesting
involvement of the domains in cross-
linking of mucus gels after protein
secretion interactions (45, 47). CysD
domains from MUC5AC have also been
reported to form noncovalent, pH-
independent dimers (47), although another
paper reported predominantly monomers
(48). In several lower organisms, the CysD
domains in the mucin genes are encoded in
separate exons, a mechanism that is
thought to increase polymorphic variants
in the mRNA via alternative splicing (23,
42). Given the available information on
these domains, it is likely that variation in
total number (as seen in this manuscript)
will alter the density of mucus gel
crosslinks, altering the mesh size,
permeability, or binding properties of
mucus and potentially influencing disease
pathophysiology.
Conclusions and Relevance
We have used PacBio’s SMRT sequencing
to resolve the sequence gap in human
MUC5AC and to identify genetic variations,
including segmental duplications, in the
large central exon. Future studies to
annotate these structural variations and
other genetic variants in a larger
population will set the stage for focused
genetic association studies in a variety of
disease cohorts where MUC5AC is
predicted to have a key role. These diseases
include common respiratory conditions
(CF, COPD, asthma, and idiopathic
pulmonary fibrosis), inflammatory bowel
disease, susceptibility to Heliocobacter (the
most common infection worldwide),
parasitic infections (such as nematode
infections) (7), and tumor development.
The strategies used in this study may
also be relevant for studies involving
other genetic regions with highly
repetitive sequences and for filling other
genomic gaps that still exist in reference
genomes. n
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Aird D, Stevens C, Robinson JT, et al. Mutations causing medullary
cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by
massively parallel sequencing. Nat Genet 2013;45:299–303.
17. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE,
Fingerlin TE, Zhang W, Gudmundsson G, Groshong SD, et al. A
common MUC5B promoter polymorphism and pulmonary fibrosis. N
Engl J Med 2011;364:1503–1512.
18. Stock CJ, Sato H, Fonseca C, Banya WA, Molyneaux PL, Adamali H,
Russell AM, Denton CP, Abraham DJ, Hansell DM, et al. Mucin 5B
promoter polymorphism is associated with idiopathic pulmonary
fibrosis but not with development of lung fibrosis in systemic
sclerosis or sarcoidosis. Thorax 2013;68:436–441.
19. Zhang Y, Noth I, Garcia JG, Kaminski N. A variant in the promoter of
MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 2011;364:
1576–1577.
20. Guo X, Pace RG, Stonebraker JR, Commander CW, Dang AT, Drumm
ML, Harris A, Zou F, Swallow DM, Wright FA, et al. Mucin variable
number tandem repeat polymorphisms and severity of cystic fibrosis
lung disease: significant association with MUC5AC. PLoS ONE
2011;6:e25452.
21. Desseyn JL, Aubert JP, Porchet N, Laine A. Evolution of the large
secreted gel-forming mucins. Mol Biol Evol 2000;17:1175–1184.
22. Escande F, Aubert JP, Porchet N, Buisine MP. Human mucin gene
MUC5AC: organization of its 59-region and central repetitive region.
Biochem J 2001;358:763–772.
23. Lang T, Hansson GC, Samuelsson T. Gel-forming mucins appeared
early in metazoan evolution. Proc Natl Acad Sci USA 2007;104:
16209–16214.
24. Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the
polymeric mucins in airways mucus. Annu Rev Physiol 2008;70:
459–486.
25. Vinall LE, Hill AS, Pigny P, Pratt WS, Toribara N, Gum JR, Kim YS,
Porchet N, Aubert JP, Swallow DM. Variable number tandem repeat
polymorphism of the mucin genes located in the complex on
11p15.5. Hum Genet 1998;102:357–366.
26. Fowler J, Vinall L, Swallow D. Polymorphism of the human muc genes.
Front Biosci 2001;6:D1207–D1215.
27. Rousseau K, Swallow DM. Mucin methods: genes encoding mucins
and their genetic variation with a focus on gel-forming mucins.
Methods Mol Biol 2012;842:1–26.
28. Zhang X, Davenport KW, Gu W, Daligault HE, Munk AC, Tashima H,
Reitenga K, Green LD, Han CS. Improving genome assemblies by
sequencing PCR products with PacBio. Biotechniques 2012;53:
61–62.
29. English AC, Richards S, Han Y, Wang M, Vee V, Qu J, Qin X, Muzny
DM, Reid JG, Worley KC, et al. Mind the gap: upgrading genomes
with Pacific Biosciences RS long-read sequencing technology. PLoS
ONE 2012;7:e47768.
30. Zheng S, Byrd AS, Fischer BM, Grover AR, Ghio AJ, Voynow JA.
Regulation of MUC5AC expression by NAD(P)H:quinone
oxidoreductase 1. Free Radic Biol Med 2007;42:1398–1408.
31. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F,
Zariwala M, Fargo D, Xu A, Dunn JM, et al.; Gene Modifier Study
Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J
Med 2005;353:1443–1453.
32. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL.
Primer-BLAST: a tool to design target-specific primers for
polymerase chain reaction. BMC Bioinformatics 2012;13:134.
33. Bikandi J, San Millán R, Rementeria A, Garaizar J. In silico analysis of
complete bacterial genomes: PCR, AFLP-PCR and endonuclease
restriction. Bioinformatics 2004;20:798–799.
34. Chevreux B, Pfisterer T, Drescher B, Driesel AJ, Müller WE, Wetter T,
Suhai S. Using the miraEST assembler for reliable and automated
mRNA transcript assembly and SNP detection in sequenced ESTs.
Genome Res 2004;14:1147–1159.
35. Meezaman D, Charles P, Daskal E, Polymeropoulos MH, Martin BM,
Rose MC. Cloning and analysis of cDNA encoding a major airway
glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem
1994;269:12932–12939.
36. Bolisetty MT, Beemon KL. Splicing of internal large exons is defined by
novel cis-acting sequence elements. Nucleic Acids Res 2012;40:
9244–9254.
37. Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, Peluso P, Rank D,
Baybayan P, Bettman B, et al. Real-time DNA sequencing from
single polymerase molecules. Science 2009;323:133–138.
38. Ewing B, Green P. Base-calling of automated sequencer traces using
phred: II. Error probabilities. Genome Res 1998;8:186–194.
39. Marques-Bonet T, Girirajan S, Eichler EE. The origins and impact of
primate segmental duplications. Trends Genet 2009;25:443–454.
40. Stankiewicz P, Lupski JR. Structural variation in the human genome
and its role in disease. Annu Rev Med 2010;61:437–455.
41. Rousseau K, Byrne C, Griesinger G, Leung A, Chung A, Hill AS,
Swallow DM. Allelic association and recombination hotspots in the
mucin gene (MUC) complex on chromosome 11p15.5. Ann Hum
Genet 2007;71:561–569.
42. Desseyn JL. Mucin CYS domains are ancient and highly conserved
modules that evolved in concert. Mol Phylogenet Evol 2009;52:
284–292.
43. Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L,
Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, et al. Genome-wide
association and linkage identify modifier loci of lung disease severity
in cystic fibrosis at 11p13 and 20q13.2. Nat Genet 2011;43:539–546.
44. Spada F, Steen H, Troedsson C, Kallesoe T, Spriet E, Mann M,
Thompson EM. Molecular patterning of the oikoplastic epithelium of
the larvacean tunicate Oikopleura dioica. J Biol Chem 2001;276:
20624–20632.
45. Ambort D, van der Post S, Johansson ME, Mackenzie J, Thomsson E,
Krengel U, Hansson GC. Function of the CysD domain of the gel-
forming MUC2 mucin. Biochem J 2011;436:61–70.
46. Thornton DJ, Howard M, Khan N, Sheehan JK. Identification of two
glycoforms of the MUC5B mucin in human respiratory mucus:
evidence for a cysteine-rich sequence repeated within the molecule.
J Biol Chem 1997;272:9561–9566.
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